Rein Therapeutics Inc. (RNTX) — Dilution Risk Analysis
Current Snapshot
Rein Therapeutics Inc. (RNTX) has a DilutionWatch score of 43/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 43/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
1 shelf registration or ATM offering filing detected in recent history.
Recent filing forms in the source payload: XBRL 2, 424B5 1, EFFECT 1, S-1 1, 8-K 1.
| Form | Filed | Accession |
|---|---|---|
| xbrl | 2026-06-30 | xbrl-6275-xbrl_warrant |
| 424B5 | 2026-05-04 | 0001193125-26-202429 |
| EFFECT | 2026-04-30 | 9999999995-26-001417 |
| S-1 | 2026-04-28 | 0001193125-26-187803 |
| 8-K | 2026-03-02 | 0001193125-26-084012 |
| xbrl | 2024-12-31 | xbrl-6275-xbrl_convertible |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Shelf registration capacity | $498,000,000 | Source |
| ATM offering capacity remaining | $8,100,000 | Source |
| Cash runway | 25 months | Source |
| Three-year share count growth | 1799.67% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 43/10) Source
- Cash Runway
- 25 months Source
- ATM Offering Capacity Remaining
- $8,100,000 Source
- Shelf Registration Capacity
- $498,000,000 Source
- Share Count Growth (3-Year)
- 1799.67% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.